GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optus Pharmaceutical Co Ltd (XKRX:131030) » Definitions » Ending Cash Position

Optus Pharmaceutical Co (XKRX:131030) Ending Cash Position : ₩25,827 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Optus Pharmaceutical Co Ending Cash Position?

Optus Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩25,827 Mil.

Optus Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2023 (₩14,411 Mil) to Dec. 2023 (₩17,811 Mil) and increased from Dec. 2023 (₩17,811 Mil) to Mar. 2024 (₩25,827 Mil).

Optus Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (₩32,555 Mil) to Dec. 2022 (₩10,409 Mil) but then increased from Dec. 2022 (₩10,409 Mil) to Dec. 2023 (₩17,811 Mil).

Optus Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Optus Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optus Pharmaceutical Co Ending Cash Position Chart

Optus Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35,157.07 42,422.63 32,555.28 10,408.97 17,810.98

Optus Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,425.34 16,047.50 14,410.89 17,810.98 25,826.61

Optus Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Optus Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=10408.965+7402.018
=17,811

Optus Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=17810.984+8015.621
=25,827

Optus Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Optus Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Optus Pharmaceutical Co (XKRX:131030) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optus Pharmaceutical Co Ltd (XKRX:131030) » Definitions » Ending Cash Position
Comparable Companies
XKRX:012790 XKRX:017180 XKRX:041910 XKRX:000220 XKRX:175250 XKRX:142280 XKRX:204840 XKRX:034940 XKRX:314140 XKRX:318010 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
50, Osongsaengmyeong-6-ro Osong-eub, Heungduk-gu Cheongju-si Chungcheongbuk-do, Mansu-li, KOR, 28158
Website
http://www.optuspharm.com
Optus Pharmaceutical Co Ltd is engaged in the manufacturing of finished medicaments.

Optus Pharmaceutical Co (XKRX:131030) Headlines

No Headlines